- Filed
- Aug 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 4, 2025 | 16.47M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 16.45M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 16.36M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 16.12M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 16.14M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $0 |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $10.37M |
| Capex | Q2 2025 · Jun 30, 2025 | $63.49M |
| Capex | Q2 2025 · Jun 30, 2024 | $55.99M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $31.18M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $68.19M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $4.59B |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $14.69M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $13.25M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $56.39M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $16.85M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $48.77M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | −$39.91M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $14.83M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $84.02M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $603.36M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $1.17B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $1.71B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $253.14M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $213.79M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $5.11B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $5.07B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $247.14M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $175.52M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $5.07B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $5.15B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$3.81 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$8.19 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$35.78 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$69.18 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$3.81 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$8.19 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$35.78 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$69.18 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $52.94M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $103.57M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $34.55M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $69.41M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$62.64M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$133.96M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$576.73M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$1.12B |
| Operating Income | Q2 2025 · Jun 30, 2025 | $16.58M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $26.32M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$523.93M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$1.01B |
| Revenue | Q2 2025 · Jun 30, 2025 | $241.57M |
| Revenue | Q2 2025 · Jun 30, 2025 | $472.9M |
| Revenue | Q2 2025 · Jun 30, 2024 | $233.48M |
| Revenue | Q2 2025 · Jun 30, 2024 | $467.98M |